CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 10 enrolled
Drug / intervention
METVIXIA Cream +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02511145
NCT02511145Phase 1Completed
CompareCT.gov

Exploratory Study to Compare Mechanical Penetration Enhancers on Metvixia Skin Penetration

Galderma R&D·interventional·Posted Jul 29, 2015·Updated May 1, 2026

In Brief

A Phase 1 clinical trial evaluating occlusive bandage, ablative fractional CO2 laser pretreatment, and 2 other interventions for Healthy. Completed, enrolled 10 participants.

Detailed Summary

Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 29, 2015
Enrollment StartFeb 1, 2014
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.9 years ago

Interventions

occlusive bandageother

ablative fractional CO2 laser pretreatmentdevice

Microneedles pretreatmentdevice

METVIXIA Creamdrug